Nuzenio

Mirum Pharmaceuticals

Mirum Pharmaceuticals news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 17 latest news signals 8 publisher sources 100/100 entity strength

Latest news

Mirum Pharmaceuticals (MIRM) Is Down 5.0% After Wider Losses and Volixibat Delay - What's Changed - simplywall.stsimplywall.st · Sat, 08 Aug 2026 07:38:07 GMTA Quick Look at Today's Ratings for Mirum Pharmaceuticals(MIRM.US), With a Forecast Between $118 to $140 - MoomooMoomoo · Fri, 07 Aug 2026 22:03:25 GMTMirum Pharmaceuticals, Inc. Stock 12‑Month Price Target Cut to $138.21, Implies 31% Upside - TradingViewTradingView · Thu, 06 Aug 2026 17:20:21 GMTFMR LLC reveals 6.2% Mirum Pharmaceuticals (MIRM) ownership in Schedule 13G - Stock TitanStock Titan · Thu, 06 Aug 2026 14:34:54 GMTRBC Capital Adjusts Mirum Pharmaceuticals PT to $135 From $148, Maintains Outperform Rating - marketscreener.commarketscreener.com · Thu, 06 Aug 2026 14:05:57 GMTMIRUM PHARMACEUTICALS, INC. : H.C. WAINWRIGHT CUTS TARGET PRICE TO $140 FROM $185 - BitgetBitget · Thu, 06 Aug 2026 02:08:45 GMTMirum Pharmaceuticals, Inc. Q2 2026 Earnings Call Summary - Yahoo FinanceYahoo Finance · Thu, 06 Aug 2026 02:02:00 GMTMirum Pharmaceuticals Q2 Loss Widens, Revenue Rises; Shares Fall - MoomooMoomoo · Wed, 05 Aug 2026 21:58:59 GMT

Timeline

Sat, 08 Aug 2026 07:38:07 GMTMirum Pharmaceuticals (MIRM) Is Down 5.0% After Wider Losses and Volixibat Delay - What's Changed - simplywall.st
Fri, 07 Aug 2026 22:03:25 GMTA Quick Look at Today's Ratings for Mirum Pharmaceuticals(MIRM.US), With a Forecast Between $118 to $140 - Moomoo
Thu, 06 Aug 2026 17:20:21 GMTMirum Pharmaceuticals, Inc. Stock 12‑Month Price Target Cut to $138.21, Implies 31% Upside - TradingView
Thu, 06 Aug 2026 14:34:54 GMTFMR LLC reveals 6.2% Mirum Pharmaceuticals (MIRM) ownership in Schedule 13G - Stock Titan
Thu, 06 Aug 2026 14:05:57 GMTRBC Capital Adjusts Mirum Pharmaceuticals PT to $135 From $148, Maintains Outperform Rating - marketscreener.com
Thu, 06 Aug 2026 02:08:45 GMTMIRUM PHARMACEUTICALS, INC. : H.C. WAINWRIGHT CUTS TARGET PRICE TO $140 FROM $185 - Bitget

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Mirum Pharmaceuticals.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

8 distinct publisher/source names are currently connected to this entity page.